tirzepatide with creatine Frontiers CREATINE AND OZEMPIC: Should You

These conversations let your provider: Adjust the dose Recommend dietary tactics Offer medication to control symptoms Create an Open, Nonjudgmental Dialogue Share: What you are eating

Tirzepatide, a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound), typically produces substantial weight reduction, but this progress naturally slows over time

Tirzepatide produced a significantly greater reduction in body weight than placebo, with a mean change of 10.3 kg (95% confidence interval [CI], 12.8 to 7.7) in the tirzepatide group versus 0.7 kg in the placebo group, yielding an estimated treatment difference of 8.7 kg (95% CI, 12.0 to 5.5

Some patients also time their drinking relative to their injection day injecting on Monday and drinking on Friday, for example, when the drug's peak plasma concentration has passed

This is especially true for people who have a history of yo-yo dieting, restrictive eating, or eating disorders